LARGACTIL 25 LIQUID

Country: Kanada

Lingwa: Ingliż

Sors: Health Canada

Ingredjent attiv:

CHLORPROMAZINE (CHLORPROMAZINE HYDROCHLORIDE)

Disponibbli minn:

SANOFI-AVENTIS CANADA INC

Kodiċi ATC:

N05AA01

INN (Isem Internazzjonali):

CHLORPROMAZINE

Dożaġġ:

25MG

Għamla farmaċewtika:

LIQUID

Kompożizzjoni:

CHLORPROMAZINE (CHLORPROMAZINE HYDROCHLORIDE) 25MG

Rotta amministrattiva:

ORAL

Unitajiet fil-pakkett:

500ML

Tip ta 'preskrizzjoni:

Prescription

Żona terapewtika:

PHENOTHIAZINES

Sommarju tal-prodott:

Active ingredient group (AIG) number: 0106167001; AHFS:

L-istatus ta 'awtorizzazzjoni:

CANCELLED POST MARKET

Data ta 'l-awtorizzazzjoni:

2006-07-28

Karatteristiċi tal-prodott

PRESCRIBING INFORMATION
LARGACTIL
CHLORPROMAZINE HYDROCHLORIDE DROPS
40 MG/ML
CHLORPROMAZINE HYDROCHLORIDE SUPPOSITORIES
100 MG
CHLORPROMAZINE HYDROCHLORIDE LIQUID
25 MG/ML
_ _
NEUROLEPTIC
sanofi-aventis Canada Inc.
Revision Date:
2150 St. Elzear Blvd. West
October 13, 2006
Laval, Quebec H7L 4A8
Submission Control No. 107341
s-a version 3.0 dated
_Page 2 of 11_
NAME OF DRUG
LARGACTIL
CHLORPROMAZINE HYDROCHLORIDE DROPS
CHLORPROMAZINE HYDROCHLORIDE SUPPOSITORIES
CHLORPROMAZINE HYDROCHLORIDE LIQUID
THERAPEUTIC CLASSIFICATION
Neuroleptic
ACTION
Chlorpromazine is a phenothiazine of the aminopropyl group. It is a
potent antipsychotic
and sedative agent which can control various states of emotional
tension, agitation,
hyperactivity and confusion. In addition, it exerts an anti-emetic
action and potentiates
the effects of narcotics, barbiturates and analgesics.
INDICATIONS
In psychiatry - schizophrenia, manic depressive psychoses (manic
phase), behavioural
disorders, involutional psychoses, senile psychoses and confusional
states in the
elderly.
In general medicine - nausea, vomiting; persistent hiccup and organic
conditions
associated with emotional stress: acute or chronic alcoholism and for
the treatment of
withdrawal symptoms of addicts and alcoholics.
In obstetrics and surgery - as a preoperative medication for the
relief of apprehension;
to reduce, by potentiation, narcotic and analgesic requirements; as an
antiemetic; to
prevent and treat traumatic or postoperative shock; for use in
artificial hibernation and
controlled hypotension.
_Page 3 of 11_
CONTRAINDICATIONS
Severe CNS depression or comatose states due to alcohol, barbiturates,
analgesics or
other CNS depressants. In patients with blood dyscrasias, severe liver
disease or a
sensitivity to phenothiazines.
WARNINGS
As with other neuroleptics, very rare cases of QT interval
prolongation have been
reported with LARGACTIL. Neuroleptic phenothiazines may potentiate QT
interval
prolongation, which increases the risk of onset of serious ventricular
arrhythmias of t